Lacosamide
NDC 0121-3036, Lacosamide, solution, from PAI Holdings, LLC dba PAI Pharma.
- Product NDC
- 0121-3036
- Status
- Listed
- Labeler
- PAI Holdings, LLC dba PAI Pharma
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216151
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/0121-3036 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LACOSAMIDE150 mg/15mL
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0121-3036-95 | 00121303695 | 1 TRAY in 1 CASE (0121-3036-95) / 10 CUP, UNIT-DOSE in 1 TRAY / 15 mL in 1 CUP, UNIT-DOSE (0121-3036-15) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/75de00d8-d2e7-4025-be4e-f49299068e7e
Use it
Look up 0121-3036 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0121-3036 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0121-3036. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.